Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinics and Research in Hepatology and Gastroenterology|December 4, 2020
Treatment of hepatitis C virus infectionLucia Parlati, Clémence Hollande, Stanislas Pol
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Micro-elimination of hepatitis C virusClémence Hollande, Lucia Parlati, Stanislas Pol
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 22, 2014
Necrotizing pancreatitis complicated by oesophageal haemorrhageGeorgia Malamut, Charles Foulkes, Laure Fournier, et al.
Journal of Clinical Medicine|June 10, 2023
Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive StudyLucia Parlati, Kennie Marcin, Benoit Terris, et al.
Frontiers in Pediatrics|March 14, 2022
Factors and Mechanisms Involved in Acquired Developmental Defects of Enamel: A Scoping ReviewAnne-Margaux Collignon, Jean-Noël Vergnes, Alice Germa, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysisErman Akkus, Christian Hobeika, Julien Edeline, et al.
Medicine|March 18, 2016
Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency VirusClémence Hollande, Vincent Mallet, Stéphane Darbeda, et al.
European Journal of Radiology|March 19, 2021
LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?Maxime Barat, Thi Thuy Linh Nguyen, Clémence Hollande, et al.
Nature Immunology|February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growthClémence Hollande, Jeremy Boussier, James Ziai, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabErwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
Pageof 3